期刊
CANCER LETTERS
卷 402, 期 -, 页码 16-31出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2017.05.010
关键词
Bee venom; Melittin; Melittin conjugates; Cancer management; Anti-cancer effects
类别
资金
- Egyptian Ministry for Higher Education
- ACS [120038-MRSG-11-019-01-CNE]
Melittin (MEL), a major peptide component of bee venom, is an attractive candidate for cancer therapy. This agent has shown a variety of anti-cancer effects in preclinical cell culture and animal model systems. Despite a convincing efficacy data against variety of cancers, its applicability to humans has met with challenges due to several issues including its non-specific cytotoxicity, degradation and hemolytic activity. Several optimization approaches including utilization of nanoparticle based delivery of MEL have been utilized to circumvent the issues. Here, we summarize the current understanding of the anticancer effects of bee venom and MEL on different kinds of cancers. Further, we also present the available information for the possible mechanism of action of bee venom and/or MEL. (C) 2017 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据